Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1(2)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.

Authors : Mukku, Roy B; Fonarow, Gregg C; Watson, Karol E

Subjects: Adrenergic beta-Antagonists: therapeutic use; Angiotensin-Converting Enzyme Inhibitors: therapeutic use; Antineoplastic Agents: adverse effects

Source: Journal of cardiac failure. 22(6)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

Authors : Chen, Ching-Hsien; Statt, Sarah; Chiu, Chun-Lung

Subjects: Animals; Cell Culture Techniques; Cell Line

Source: American journal of respiratory and critical care medicine. 190(10)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

A Single-Arm, Open-Label, Expanded Access Study of Vemurafenib in Patients With Metastatic Melanoma in the United States

Authors : Flaherty, Lawrence; Hamid, Omid; Linette, Gerald

Subjects: Cancer; Clinical Trials and Supportive Activities; Patient Safety

Source: The Cancer Journal. 20(1)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.

Authors : Meyskens, Frank L, Jr; Simoneau, Anne R; Gerner, Eugene W

Subjects: Biosynthetic Pathways: drug effects; Chemoprevention: methods; Eflornithine: therapeutic use

Source: Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer. 202

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

Authors : Hershman, Dawn L; Unger, Joseph M; Crew, Katherine D

Subjects: Acetylcarnitine: administration & dosage; adverse effects; Adult

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care.

Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors.

Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy

Managing Pharmacotherapy in People Living With HIV and Concomitant Malignancy.

Retinoids and carotenoids in the prevention of oral cancer: a critical appraisal.

Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.

Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.

A Single-Arm, Open-Label, Expanded Access Study of Vemurafenib in Patients With Metastatic Melanoma in the United States

Chemoprevention of prostate cancer with the polyamine synthesis inhibitor difluoromethylornithine.

Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.

اتصل بنا

اتبع